Klaus Bosslet, PhDManaging Director at TheraPharm Deutschland GmbH
Klaus Bosslet earned his Ph.D in 1980 at the University of Heidelberg/ German Cancer Research Center (DKFZ) in the field of Tumour Immunology.
His professional career is dedicated to R+D in Oncology. He worked in cellular immunology, monoclonal antibodies, imaging, antibody enzyme fusion proteins, Pro-drug activation systems, signaling, cytolytic fusion proteins and finally in antibody targeted radio therapy.
Klaus has published more than 115 publications.
His last 3 industry positions preceding the actual position as managing Director at TheraPharm Deutschland GmbH were:
- Site Head Discovery Oncology, Roche Pharmaceuticals – (2011-2015)
- Global VP Oncology Research, MedImmune – (2008-2010)
- Global Head Therapeutic Research Oncology, Schering AG/Bayer Schering Pharma – (1998-2008